Summary.-The previously described glycoprotein that promotes tumour cell aggregation, derived from rat ascites hepatoma cells and capable of partial purification by chromatography, was found to be a mixture of 2 factors with different antigenic property. One was not absorbed by immunoadsorbent chromatography with anti-rat serum antibody and the other was. The action of the unabsorbed factor was clearly more potent than that of the absorbed factor. Both the factors were found in the serum of tumour bearing rats and the action of the unabsorbed factor was also more potent than that of the absorbed factor; its amount increased with time after i.p. inoculation of the cells. The serum of healthy rats contained the absorbed factor but not the unabsorbed factor. It was thus assumed that the unabsorbed factor was associated with the hepatoma cell surface itself and released into the serum, while the absorbed factor was associated with serum protein coating the cell. (Ishimaru, Ishihara and Hayashi, 1975) .
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As PREVIOUSLY described (Kudo et al., 1974) (Ishimaru, Ishihara and Hayashi, 1975) .
It was thus assumed that the substance might be involved in the development of such binding structures as a triggering mechanism of tumour cell adhesiveness. The purpose of the present communication is to record the evidence that the substance described above is a mixture of 2 tumour cell aggregation inducing factors with different antigenic property; the one may be associated with hepatoma cell surface and the other with serum protein coating the cell surface.
MATERIALS AND METHODS
Rat ascites hepatoma.-Rat ascites hepatoma AH136B (Odashima, 1962) and AH109A (Odashima, 1964) have been maintained in our laboratory by routine 10-day interval passage of 1 x 106 AH136B cells or by routine weekly passage of 2 x 106 AH109A cells injected i.p. into 80-100 g male rats of the Donryu strain. The majority (about 98%) of AH136B cells were found to form cell islands of varying size in vivo. On the other hand, most (about 98%) of AH109A cells were found to be free in vivo. * This is No. 3 of the studies on tumrour cell aggregation piomoting factor.
In vitro assay for cell aggregation. This was performed essentially by the method previously described (Kudo et al., 1974 Preparation of cell suspension. AH109A cell suspension was prepared as follows (lshimaru et al., 1975) : the ascites fluid (20 ml) withdrawn by i.p. puncture 7 days after inoculation of AH109A cells and diluted 1: 5 with 0 450% NaCl solution. After washing with 3 changes of 0-45 00 NaCl and 2 changes of Hanks' balanced salt solution, tumour cells were sedimented by centrifugation at 25 g for 10 min. The cells were finally suspended at a concentration of 1 5 x 106 cells/ml in Hanks' balanced salt solution. As previously described (Ishimaru et al., 1975) , the aggregation promoting factor, separated from AH136B cells, showed a similar effect for aggregation of AH109A cells when tested at concentration of 5 x 105 cells/ml (Kudo et al., 1974) . The cell suspension was convenient for the present experiment because the majority of AH109A cells were present in a free form in vivo. On the other hand, AH136B cells needed previous dissociation, because of in vivo island formation of the cells (Kudo et al., 1974) .
Isolation of aggregation promiaoting factor from tumour cells (tumnour cell APF). This was carried out essentially by the method previously described (Kudo et al., 1974) . APF was released from 15 x 108 AH136B cells, suspended in Hanks' balanced salt solution (free of calcium and magnesium), received 50 gentle pipettings and was then allowed to stand for 3 h in the cold (0°C). The supernatant fluid, obtained after centrifugation at 300 g for 10 min and then at 10,000 g for 30 min, was filtered through Millipore filters (pore size 0-3 /um). The supernatant fluid (10-20 ml, absorbancy 5-7 at 280 nm/ml) wAas applied to a column (2 0 x 20-0 cm) of DEAE-Sephadex equilibrated with 0-02 mol/l phosphate buffer (pH 6.8). The flowr rate was 20 ml/h and 5 g effluent fractions w%ere collected. The second peak (eluted in 0-02 mol/l plhosphate buffer plus 0-3 mol/l NaCl on DEAE-Sephadex; 5 ml, absorbancy 4-6 at 280 nm/ml) was placed on a Biogel A-5m column (2-0 x 90.0 cm) equilibrated -with Hanks' balanced salt solution. Filtration w as performed at a rate of 5 drops/min and 4 g effluent fractions were collected. The second component was used as tumour cell APF.
Preparation of antisera and antibody.-Antisera against rat serum were prepared in rabbits (2-5-3-0 kg) by repeated intraderinal injections of healthy rat serum (0 5 ml, once per w8eek, 6-8 w-eeks) with Freund's complete adjuvant (Difco, Detroit, Michigan, U.S.A.). Only antisera w%ith titres of 27-28, measured by routine precipitin test, were used. From the antisera, the antibody fraction was separated at 3300 saturation with ammonium sulphate. Antisera against tumour cell APF or unabsorbed tumour cell APF, as described below, were respectively prepared in rabbits (2-5-3-0 kg) by repeated intradermal injections of each APF (3 mg, once per wieek, 6-8 weeks) with Freund's complete adjuvant; intradermal injections, in divided dose, were given at 30 sites in the back, abdomen and proximal limbs of the animals. One w-eek later, a booster injection (3 mg APF in 20 ml of physiological saline containing 0 5 mg antihistamine) (Polaramine, Schering Co., Bloomfield, New Jersey, U.S.A.) was given, followed by a similar injection one w%Neek later. Only antisera with titres of 26-2 , measured by routine precipitin test, wN-ere used.
Preparation of im,munooadsorbent colunr,n With Sepharose 4B coupled with anti-rat serumn antibody.-The antibody fraction, separated from rabbit antisera against normal rat serum, was coupled w%Nith Sepharose 4B (Pharmnacia, Uppsala, Sweden) according to '80 the method of Porath, Axen and Ernback (1967) . At room temperature, 40 ml of cyanogen bromide (25 mg/ml in distilled water) were added to a volume of Sepharose 4B suspension corresponding to 10 g Sepharose. The pH was rapidly adjusted to 11 and kept constant for 6 min by continuous addition of 2-0 mol/l sodium hydroxide. The reaction mixture was gently stirred during the process. The gel was immediately washed on a glass filter with ice water, and mixed with the antibody fraction (800 mg) which was dialysed against 01 mol/l sodium hydrogen carbonate for 16 h at 4°C. After sitrring gently for 16 h at 4°C, the mixture was washed on a glass filter with 0-1 mol/l sodium hydrogen carbonate to remove free protein and then with 0-02 mol/l phosphate buffer (pH 6.8).
Estimation of protein concentration.-This was performed by the method of Lowry et al. (1951) Ouchterlony (1958) . The tumour cell Fig. 1 ). On the other hand, the normal serum APF, which was similarly eluted on DEAE-Sephadex and then on Biogel, as described below, gave 3 weak precipitin lines and diffusely precipitated faint mass when tested with the same antiserum as mentioned above (3, 4 in Fig. 1 ). Obvious fusion between the lines by tumour cell APF and serum APF was not revealed. It was thus suggested that tumour cell APF sample contained some components of serum.
(b) Immunoadsorbent chromatography of tumour cell APF.-The APF from tumour cells was concentrated under vacuum pressure dialysis to give an adsorbancy 2-3 at 280 nm/ml. Five ml of the concentrated APF were applied to a column (2.0 x 8 0 cm) of Sepharose 4B coupled with rabbit anti-rat serum antibody previously equilibrated with 0-02 mol/l phosphate buffer (pH 6.8). Elution was done by change of eluting buffers as follows: (1) 0-02 mol/l phosphate buffer (pH 6-8) and (2) 1-0 mol/l acetic acid (pH 2.4). The flow rate was 18 ml/h and 5 g effluent fractions were collected. The total yield was about 990 of the applied sample measured as the absorbancy at 280 nm; the first comprised 67%o and the second 32%. The first (unabsorbed) component was clearly potent for aggregation of AH109A cells (Fig. 2a) . On the other hand, the potency of the second (absorbed) component was apparently less marked (Fig. 2a) . In order to avoid a problem due to column overloading, the first (unabsorbed) component was re-chromatographed under the same conditions as mentioned above. The recovery of the applied sample was about 970/ and concentrated in the first (unabsorbed) component; the component was similarly active (Fig. 2b) . When the assay was done by agar immunodiffusion with rabbit antiserum against the unabsorbed component, i.e., unabsorbed tumour cell APF, the unadsorbed APF gave only 2 distinct precipitin lines (1, 2 in Fig. 3 (Kudo et al., 1974) , each serum sample (3-4 ml, absorbancy 40-60 at 280 nm/ml) was applied to a column (2 0 x 20.0 cm) of DEAE-Sephadex A-50 equilibrated with 0-02 mol/l phosphate buffer (pH 6.8), and eluted by stepwise concentration changes of eluting buffers. APF, eluted in 0-02 mol/l phosphate buffer plus 0 3 mol/l NaCl, was further eluted on Biogel equilibrated with Hanks' balanced salt solution; and the second component eluted was used as the serum APF. APF activity of tumour bearing rat serum was more potent than that of healthy rat serum, and seemed to increase gradually according to the duration after i.p. inoculation of the cells (Table) . (Fig. 4a) . The first component was more potent for AH109A cell aggregation than the second component. The first component was re-chromatographed under the same conditions as described above. The recovery of the applied sample was about 99%; the first comprised 57% and the second 42% (Fig. 4b) . The first component was more active than the second component. In order to obtain precise results, the first component was further re-chromatographed under the same conditions as noted above. The recovery of the applied sample was about 98% and concentrated in the first component; the component was clearly active (Fig. 4c) . On the other hand, APF activity of normal rat serum, although apparently less marked, was found only in the second (absorbed) component (Fig. 5) . When the APF samples after rechromatography were tested by agar immunodiffusion, the unabsorbed tumour serum APF gave only one distinct precipitin line with antiserum against the unabsorbed tumour cell APF noted above (2 in Fig. 6 ), but the absorbed tumour serum APF produced no precipitin line with the same antiserum (1 in Fig. 6 ), indicating that the unabsorbed tumour serum APF shares antigenic sites common with the unabsorbed tumour cell APF, but not with the adsorbed tumour serum APF. On the other hand, the absorbed tumour serum APF gave 2 distinct precipitin lines and one weak precipitin line with antiserum against normal rat serum (3 in Fig. 6 ), but the unabsorbed tumour serum APF did not give any precipitin line with the antiserum (2 in Fig. 6 ). Further agar immunodiffusion analysis confirmed the following: the unabsorbed tumour serum APF gave only one distinct precipitin line with antiserum against the unabsorbed tumour cell APF noted above (1 in Fig. 7) , which fused obviously one of 2 precipitin lines produced by the unabsorbed tumour cell APF and the antiserum (2 in Fig. 7) . The absorbed normal serum APF (3 in Fig. 7) or the unabsorbed normal serum component (4 in Fig. 7 ) produced no precipitin line with the antiserum described above, indicating that the absorbed normal serum APF has the different antigenic property with the unabsorbed tumour cell and serum APF. 
DISCUSSION
The observations presented here demonstrated that a tumour cell APF, isolated from rat ascites hepatoma cells by the method previously described (Kudo et al., 1974) The unabsorbed tumour serum APF gave one distinct precipitin line with rabbit antiserum against the unadsorbed tumour cell APF, but did not produce any precipitin line with rabbit antiserum against normal rat serum. The absorbed tumour serum APF produced 2 distinct and one weak precipitin lines with antiserum against normal rat serum, but not with antiserum against the unabsorbed tumour cell APF. A, rabbit antiserum against unabsorbed tumour cell APF; B, rabbit antiserum against normal rat serum; 1 and 3, absorbed tumour serum APF (3 mg/ml); 2, unabsorbed tumour serum APF (3 mg/ml).
as confirmed on the unabsorbed tumour cell APF. Since the unabsorbed tumour serum APF shared the antigenic sites common with the unabsorbed tumour cell APF, it was suggested that both the unabsorbed APF may be similar or identical in nature. On the other hand, since the absorbed tumour serum APF had the common antigenic property with the absorbed normal serum APF, but not with the unabsorbed tumour cell APF or the unabsorbed tumour serum APF, it was assumed that both the absorbed APF may be similar or identical in nature but were different from both the unabsorbed APF. The serum of healthy rats contained the absorbed APF but not the unabsorbed APF. Since both the absorbed serum APF from healthy and tumour bearing rats were similarly less active-for induction of AH109A cell aggregation, and the potency of the absorbed tumour serum APF was independent of the duration after i.p. inoculation of tumour cells, it was presumed that the unabsorbed APF in tumour bearing rat serum was released from the tumour cell surface; the APF potency was increased gradually according to the duration after inoculation of FIG. 7. Agar immunodiffusion of tumour cell and serum APF after immunoadsoibenit chromatography. The unabsorbed tumour serum APF gave a distinct, precipitin line with antiserum against the unabsorbed tumour cell APF, which fused one of 2 precipitin lines produce(l by the unabsorbed tumour cell APF and the antiserum. The absorbed normal serum APF or unabsorbed normal serum component did not give any precipitin line with the antiseruim. A, rabbit antiserum against, the unabsorbed tumour cell APF; 1, unabsorbed tumour serum APF (3 mg/ml); 2, unabsorbed tumour cell APF (3 mg/ml); 3, absorbed normal rat serumn APF (3 mg/ml); 4, 1un-absorbed normal rat serum (3 mg/ml).
tumour cells. The power to induce tumour cell aggregation has been detected in the serum (Tal, Dishon and Gross, 1964 ) and ascitic fluid of cancer patients (Mori, Akedo and Tanigaki, 1970) and of tumour bearing mice (Oppenheimer and Humphreys, 1971 ). However, the problem of whether such potency may be related to an aggregation promoting factor of cancer cell origin has not yet been established. The observations reported here seemed to give an explanation on the problem. On the other hand, Witkowski and Brighton (1972) have suggested a role of serum in the attachment of human diploid cells (MRC-5) to glass surface. Weiss (1959a, b) 
